Last reviewed · How we verify
gadobenic acid
gadobenic acid is a Paramagnetic Contrast Agent drug. It is currently in unknown development.
Gadobenic acid works by altering the magnetic properties of surrounding tissues, allowing for clearer imaging of internal structures.
Gadobenic acid is a small molecule used as a diagnostic agent in magnetic resonance imaging (MRI). It is a gadolinium-based contrast medium, specifically a complex of gadolinium with the ligand BOPTA, used to enhance imaging in various conditions such as coronary artery disease and CNS lesions.
At a glance
| Generic name | gadobenic acid |
|---|---|
| Drug class | Paramagnetic Contrast Agent |
| Therapeutic area | Other |
| Phase | unknown |
Mechanism of action
Imagine you're trying to see a small object in a dark room. Gadobenic acid helps doctors see internal structures more clearly by making them slightly brighter and more visible on imaging tests. This is because the gadolinium in the agent interacts with the magnetic field used in imaging tests, making it easier to see what's going on inside the body.
Approved indications
Common side effects
Key clinical trials
- Cardiac MRI in Measuring the Impact of Anti-androgen Treatment on Cardiac Function in Patients With Prostate Cancer (NA)
- Imaging in MGUS, SMM and MM (PHASE2)
- Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years (PHASE4)
- PSMA-Targeted 18F-DCFPyL PET/MRI for the Detection of Prostate Cancer (PHASE2)
- Validity of Parametric MRI Using VIRADS (NA)
- Proof-of-concept Study for SAR441344 (Frexalimab) in Relapsing Multiple Sclerosis (PHASE2)
- Comparison of Contrast Agents in Liver MR for the Detection of Hepatic Metastases (PHASE4)
- Hybrid Molecular Imaging of ER in Breast Cancer Patients With DCIS (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- gadobenic acid CI brief — competitive landscape report
- gadobenic acid updates RSS · CI watch RSS
- portfolio CI
Frequently asked questions about gadobenic acid
What is gadobenic acid?
How does gadobenic acid work?
What drug class is gadobenic acid in?
What development phase is gadobenic acid in?
Related
- Drug class: All Paramagnetic Contrast Agent drugs
- Manufacturer: — full pipeline
- Therapeutic area: All drugs in Other
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing